摘要
这篇小综述的重点是研究新型含氮类固醇衍生物,可能适用于前列腺癌的治疗。它涵盖了过去十年的文献,突出显示在前列腺癌细胞中具有显著活性和药理效力的新类固醇化合物的结构。本文综述了目前已知的抗前列腺癌药物的新衍生物:阿比特龙和嘉列酮,含氮杂环修饰的雄甾烷和孕甾烷的新衍生物,以及一些相关的甾体类化合物。
关键词: 前列腺癌,类固醇CYP17A1抑制剂,阿比特龙,galeterone,新型氮,抗前列腺癌药物,雄激素剥夺疗法。
Current Medicinal Chemistry
Title:Novel Nitrogen Containing Steroid Derivatives for Prostate Cancer Treatment
Volume: 28 Issue: 40
关键词: 前列腺癌,类固醇CYP17A1抑制剂,阿比特龙,galeterone,新型氮,抗前列腺癌药物,雄激素剥夺疗法。
摘要: This mini-review focuses on the investigation of novel nitrogen-containing steroid derivatives that are potentially applicable for prostate cancer treatment. It covers the literature of the last decade, highlighting the structure of new steroid compounds that exhibit significant activity in prostate cancer cells and possess pharmacological potency. New derivatives of known anti-prostate cancer agents: abiraterone and galeterone, new derivatives of androstane and pregnane modified with nitrogen-containing heterocycles, and some related steroid-derived compounds are discussed in the review.
Export Options
About this article
Cite this article as:
Novel Nitrogen Containing Steroid Derivatives for Prostate Cancer Treatment, Current Medicinal Chemistry 2021; 28 (40) . https://dx.doi.org/10.2174/0929867328666210208113919
DOI https://dx.doi.org/10.2174/0929867328666210208113919 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Anti-breast Cancer Agents, Quinolines, Targeting Gap Junction
Medicinal Chemistry Cell-penetrating Peptide-mediated Nanovaccine Delivery
Current Drug Targets The Role of Oxidative Stress in Smoking-Related Diseases
Mini-Reviews in Organic Chemistry TRYCAT Pathways Link Peripheral Inflammation, Nicotine, Somatization and Depression in the Etiology and Course of Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets Versatility of Cancer Associated Fibroblasts: Commendable Targets for Anti-tumor Therapy
Current Drug Targets Current Concepts and Future Directions in Radioimmunotherapy
Current Drug Discovery Technologies Role of Redox Signaling, Protein Phosphatases and Histone Acetylation in the Inflammatory Cascade in Acute Pancreatitis: Therapeutic Implications
Inflammation & Allergy - Drug Targets (Discontinued) Synthetic and Medicinal Prospective of Structurally Modified Curcumins
Current Topics in Medicinal Chemistry Pharmacogenetics and the Pharmaceutical Industry
Current Pharmaceutical Design Phosphorothioate Oligonucleotides: Effectiveness and Toxicity
Current Drug Targets Seek and Destroy: The Use of Natural Compounds for Targeting the Molecular Roots of Cancer
Current Drug Targets Nociceptin / Orphanin FQ (NOP) Receptors as Novel Potential Target in the Treatment of Gastrointestinal Diseases
Current Drug Targets Discovery of Selective Probes and Antagonists for G Protein-Coupled Receptors FPR/FPRL1 and GPR30
Current Topics in Medicinal Chemistry Structure, Function and Inhibition of Poly(ADP-ribose)polymerase, Member 14 (PARP14)
Mini-Reviews in Medicinal Chemistry Targeting Epigenetic Modifiers in Cancer
Current Medicinal Chemistry Meet Our Editorial Board Member:
The Natural Products Journal Lapatinib as a Dual Tyrosine Kinase Inhibitor Unexpectedly Activates Akt in MDA-MB-231 Triple-Negative Breast Cancer Cells
Letters in Drug Design & Discovery Prostatic Tumor Stroma: A Key Player in Cancer Progression
Current Cancer Drug Targets Thiol Proteases: Inhibitors and Potential Therapeutic Targets
Current Medicinal Chemistry Precision-cut Intestinal Slices as In Vitro Tool for Studies on Drug Metabolism
Current Drug Metabolism